Narration of the State of the Discovery Nation 2021 Report
A new wave of medicines has emerged in recent years, to supplement the established small and large molecule platforms. These complex medicines will become as important as traditional small molecule drugs in the coming years, with market values of hundreds of billions of pounds. Hear from our CSO, Prof. Peter Simpson as he talks about […]
Read more
State of the Discovery Nation 2021
Complex medicines will become as important as traditional small molecule drugs in the coming years, with market values of hundreds of billions of pounds. Pharmaceutical and biotech companies working in complex medicines in the UK include those specialising in antibody-drug conjugates, firms developing oligonucleotide therapeutics, entities focusing on proprietary delivery technologies for a range of […]
Read more